Liraglutide Injection
Lupin is recalling Liraglutide Injection (NDC 70748-346-02 and 70748-346-03) due to white thread-like particulate matter in the cartridge.
Inspect your medication for any visible particles. If you identify a white thread-like structure, do not use the product and contact your healthcare provider or pharmacist for a replacement.
Why it was recalled
Lupin Pharmaceuticals is recalling Liraglutide Injection, 18 mg/3 mL (6 mg/mL), due to the presence of particulate matter, specifically a white thread-like structure found in the cartridge. The affected products are identified by NDC 70748-346-02 (2-pen pack) and NDC 70748-346-03 (3-pen pack).
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
- Recall #
- D-0541-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Lupin Pharmaceuticals Inc.
Editorial summary by Recall Canary · last updated 2026-05-20 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification